Had A Lower Risk Of Major Or Clinically Relevant Bleeding Than Warfarin But A Higher Risk Than Placebo.

Article

Apixaban and Dabigatran Found Effective, Safe for Extended Venous Thromboembolism Therapy

Author:

Had A Lower Risk Of Major Or Clinically Relevant Bleeding Than Warfarin But A Higher Risk Than Placebo.

• Read More